Lorenzo P Menzel1, Willam Ruddick1, Mobaswar H Chowdhury1, David C Brice1, Ryan Clance1, Emily Porcelli1, Lisa K Ryan2, Jungnam Lee3, Özlem Yilmaz4,5, Keith L Kirkwood6, Laura McMahon7, Amy Tran7, Gill Diamond1. 1. Department of Oral Biology, University of Florida, Gainesville, Florida. 2. Division of Infectious Diseases and Global Medicine, Department of Medicine, University of Florida College of Medicine, Gainesville, Florida. 3. Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, Gainesville, Florida. 4. Department of Oral Health Sciences, Medical University of South Carolina, Charleston, South Carolina. 5. Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina. 6. Department of Oral Biology, State University of New York at Buffalo, Buffalo, New York. 7. Department of Oral Biology, Rutgers New Jersey Dental School, Newark, New Jersey.
Abstract
BACKGROUND AND OBJECTIVE: Both chronic and aggressive periodontal disease are associated with vitamin D deficiency. The active form of vitamin D, 1,25(OH)2 D3 , induces the expression of the antimicrobial peptide LL-37 and innate immune mediators in cultured human gingival epithelial cells (GECs). The aim of this study was to further delineate the mechanism by which vitamin D enhances the innate defense against the development of periodontal disease (PD). MATERIALS AND METHODS: Wild-type C57Bl/6 mice were made deficient in vitamin D by dietary restriction. Cultured primary and immortalized GEC were stimulated with 1,25(OH)2 D3 , followed by infection with Porphyromonas gingivalis, and viable intracellular bacteria were quantified. Conversion of vitamin D3 to 25(OH)D3 and 1,25(OH)2 D3 was quantified by ELISA. Effect of vitamin D on basal IL-1α expression in mice was determined by topical administration to the gingiva of wild-type mice, followed by qRT-PCR. RESULTS: Dietary restriction of vitamin D led to alveolar bone loss and increased inflammation in the gingiva in the mouse model. In primary human GEC and established human cell lines, treatment of GEC with 1,25(OH)2 D3 inhibited the intracellular growth of P. gingivalis. Cultured GEC expressed two 25-hydroxylases (CYP27A1 and CYP2R1), as well as 1-α hydroxylase, enabling conversion of vitamin D to both 25(OH)D3 and 1,25(OH)2 D3 . Topical application of both vitamin D3 and 1,25(OH)2 D3 to the gingiva of mice led to rapid inhibition of IL-1α expression, a prominent pro-inflammatory cytokine associated with inflammation, which also exhibited more than a 2-fold decrease from basal levels in OKF6/TERT1 cells upon 1,25(OH)2 D3 treatment, as determined by RNA-seq. CONCLUSION: Vitamin D deficiency in mice contributes to PD, recapitulating the association seen in humans, and provides a unique model to study the development of PD. Vitamin D increases the activity of GEC against the invasion of periodontal pathogens and inhibits the inflammatory response, both in vitro and in vivo. GEC can convert inactive vitamin D to the active form in situ, supporting the hypothesis that vitamin D can be applied directly to the gingiva to prevent or treat periodontal disease.
BACKGROUND AND OBJECTIVE: Both chronic and aggressive periodontal disease are associated with vitamin D deficiency. The active form of vitamin D, 1,25(OH)2 D3 , induces the expression of the antimicrobial peptide LL-37 and innate immune mediators in cultured human gingival epithelial cells (GECs). The aim of this study was to further delineate the mechanism by which vitamin D enhances the innate defense against the development of periodontal disease (PD). MATERIALS AND METHODS: Wild-type C57Bl/6 mice were made deficient in vitamin D by dietary restriction. Cultured primary and immortalized GEC were stimulated with 1,25(OH)2 D3 , followed by infection with Porphyromonas gingivalis, and viable intracellular bacteria were quantified. Conversion of vitamin D3 to 25(OH)D3 and 1,25(OH)2 D3 was quantified by ELISA. Effect of vitamin D on basal IL-1α expression in mice was determined by topical administration to the gingiva of wild-type mice, followed by qRT-PCR. RESULTS: Dietary restriction of vitamin D led to alveolar bone loss and increased inflammation in the gingiva in the mouse model. In primary human GEC and established human cell lines, treatment of GEC with 1,25(OH)2 D3 inhibited the intracellular growth of P. gingivalis. Cultured GEC expressed two 25-hydroxylases (CYP27A1 and CYP2R1), as well as 1-α hydroxylase, enabling conversion of vitamin D to both 25(OH)D3 and 1,25(OH)2 D3 . Topical application of both vitamin D3 and 1,25(OH)2 D3 to the gingiva of mice led to rapid inhibition of IL-1α expression, a prominent pro-inflammatory cytokine associated with inflammation, which also exhibited more than a 2-fold decrease from basal levels in OKF6/TERT1 cells upon 1,25(OH)2 D3 treatment, as determined by RNA-seq. CONCLUSION: Vitamin D deficiency in mice contributes to PD, recapitulating the association seen in humans, and provides a unique model to study the development of PD. Vitamin D increases the activity of GEC against the invasion of periodontal pathogens and inhibits the inflammatory response, both in vitro and in vivo. GEC can convert inactive vitamin D to the active form in situ, supporting the hypothesis that vitamin D can be applied directly to the gingiva to prevent or treat periodontal disease.
Authors: Galina D Kutuzova; Flora Sundersingh; Jennifer Vaughan; Bulli Padmaja Tadi; Susan E Ansay; Sylvia Christakos; Hector F Deluca Journal: Proc Natl Acad Sci U S A Date: 2008-12-10 Impact factor: 11.205
Authors: D M Laube; A Dongari-Bagtzoglou; H Kashleva; J Eskdale; G Gallagher; G Diamond Journal: J Periodontal Res Date: 2007-11-13 Impact factor: 4.419
Authors: Louisa E Jeffery; Fiona Burke; Manuela Mura; Yong Zheng; Omar S Qureshi; Martin Hewison; Lucy S K Walker; David A Lammas; Karim Raza; David M Sansom Journal: J Immunol Date: 2009-11-01 Impact factor: 5.422
Authors: Gill Diamond; Erika L Figgins; Tanya Robinson; Michal Senitko; George E Abraham; Haley B Williams; Meredith Sloan; Anna Owings; Hannah Laird; Yilianys Pride; Kenneth J Wilson; Mohammad Hasan; Adam Parker; Sarah C Glover Journal: Mol Oral Microbiol Date: 2020-12-08 Impact factor: 3.563
Authors: Concetta Cafiero; Cristina Grippaudo; Marco Dell'Aquila; Pasquale Cimmino; Antonio D'Addona; Paolo De Angelis; Maria Pia Ottaiano; Domenico Costagliola; Giulio Benincasa; Alessandra Micera; Luigi Santacroce; Raffaele Palmirotta Journal: Biomolecules Date: 2022-06-15